Skip to main content

TG Therapeutics, Inc. (NASDAQ: TGTX) Investor Securities Class Action Lawsuit 07/18/2022

  • If you purchased a significant amount of shares of TG Therapeutics, Inc. (NASDAQ: TGTX) between January 15, 2020 and May 31, 2022, and / or if you purchased any NASDAQ: TGTX shares prior to January 2020 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: September 16, 2022. NASDAQ: TGTX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 18, 2022 - An investor in shares of TG Therapeutics, Inc. (NASDAQ: TGTX) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by TG Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between January 15, 2020 and May 31, 2022. New York based TG Therapeutics, Inc...

You must register (for free) or login to view the entire case.